Page last updated: 2024-09-03

dioscin and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

dioscin has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Compound Research Comparison

Studies
(dioscin)
Trials
(dioscin)
Recent Studies (post-2010)
(dioscin)
Studies
(benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
Trials
(benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
25002001,8970411

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, EA; Kim, MS; Kim, YS; Lee, SJ; Lee, TJ; Park, KG; Sohn, HY1

Other Studies

1 other study(ies) available for dioscin and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

ArticleYear
Dioscin sensitizes cells to TRAIL-induced apoptosis through downregulation of c-FLIP and Bcl-2.
    Oncology reports, 2012, Volume: 28, Issue:5

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Diosgenin; Down-Regulation; Humans; Kidney Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; RNA, Messenger; TNF-Related Apoptosis-Inducing Ligand

2012